Beating both earnings and sales estimates significantly indicates strong financial health and operational efficiency. This outperformance, especially in sales, suggests that Intellia Therapeutics is growing its market share and executing its business strategy effectively. Such positive results are likely to instill investor confidence, potentially leading to a short-term uptick in stock price.